FHA Monthly Brief – April 2026
March was a consequential month. PwC published a detailed analysis of the women’s health market, making the case plainly
March was a consequential month. PwC published a detailed analysis of the women’s health market, making the case plainly
This episode is a must-listen for founders building in underdeveloped markets, investors looking upstream for the next wave of opportunity and operators working to make women’s health visible before capital arrives.
This episode is a must-listen for founders navigating the commercialization battlefield, investors allocating capital into women’s health, and operators building through the long middle before momentum is visible. In this episode of Blindspot Capital, Maryann sits down with Cristina Ljungberg and Wendy Anderson, co-founders of The Case for Her, to unpack what happens before venture capital shows up.
Last week, FemmeHealth Alliance hosted our first webinar of 2026: Women’s Hormonal Health — Why Investors Are Paying Attention. The session brought together investors and ecosystem builders across time zones to explore what is shifting beneath the headlines and what that shift means for capital allocation in women’s health.
Women’s Health Is Now Being Evaluated as Infrastructure As 2026 approaches, women’s health is no longer being evaluated as a